Evidence map›Paper›PMID 35500035›Full record

ArticlePLoS pathogens2022

Beneath the surface: Amino acid variation underlying two decades of dengue virus antigenic dynamics in Bangkok, Thailand.

Angkana T Huang, Henrik Salje, Ana Coello Escoto, Nayeem Chowdhury, Christian Chávez, Bernardo Garcia-Carreras, Wiriya Rutvisuttinunt, Irina Maljkovic Berry, Gregory D Gromowski, Lin Wang and 14 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 3 countries.

Angkana T HuangDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0002-9857-3506
Henrik SaljeDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Ana Coello EscotoDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Nayeem ChowdhuryDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Christian ChávezDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Bernardo Garcia-CarrerasDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Wiriya RutvisuttinuntViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Irina Maljkovic BerryViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Gregory D GromowskiViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Lin WangDepartment of Genetics, University of Cambridge, Cambridge, United Kingdom.
Chonticha KlungthongDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Butsaya ThaisomboonsukDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Ananda NisalakDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Luke M Trimmer-SmithDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Isabel Rodriguez-BarraquerSchool of Medicine, University of California, San Francisco, San Francisco, California, United States of America.
Damon W EllisonViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Anthony R JonesDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Stefan FernandezDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Stephen J ThomasState University of New York Upstate Medical University, Syracuse, New York, United States of America.
Derek J SmithDepartment of Zoology, University of Cambridge, Cambridge, United Kingdom.
Richard JarmanViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Stephen S WhiteheadLaboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Derek A T CummingsDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.
Leah C KatzelnickDepartment of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0003-1033-6758
University of Florida · USArmed Forces Research Institute of Medical Science · THWalter Reed Army Institute of Research · USNational Institutes of Health · USUniversity of Cambridge · GBSUNY Upstate Medical University · USUniversity of California, San Francisco · US

Funding

Laboratory And Preclinical Studies Of FlavivirusesZIAAI000891 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI WHITEHEAD, STEPHEN · 2009 to 2025
$17.5M
Immunology, virology, and epidemiology of flaviviruses and other emerging virusesZIAAI001346 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KATZELNICK, LEAH · 2021 to 2025
$7.1M
LINKING ANTIGENIC & GENETIC VARIATION OF DENGUE TO INDIVIDUAL AND POPULATION RISKR01AI114703 · NIAID · UNIVERSITY OF FLORIDA · PI CUMMINGS, DEREK A · 2015 to 2019
$3.6M
NIAID NIH HHS R01 AI114703
6 · The paper itself

Abstract

Neutralizing antibodies are important correlates of protection against dengue. Yet, determinants of variation in neutralization across strains within the four dengue virus serotypes (DENV1-4) is imperfectly understood. Studies focus on structural DENV proteins, especially the envelope (E), the primary target of anti-DENV antibodies. Although changes in immune recognition (antigenicity) are often attributed to variation in epitope residues, viral processes influencing conformation and epitope accessibility also affect neutralizability, suggesting possible modulating roles of nonstructural proteins. We estimated effects of residue changes in all 10 DENV proteins on antigenic distances between 348 DENV collected from individuals living in Bangkok, Thailand (1994-2014). Antigenic distances were derived from response of each virus to a panel of twenty non-human primate antisera. Across 100 estimations, excluding 10% of virus pairs each time, 77 of 295 positions with residue variability in E consistently conferred antigenic effects; 52 were within ±3 sites of known binding sites of neutralizing human monoclonal antibodies, exceeding expectations from random assignments of effects to sites (p = 0.037). Effects were also identified for 16 sites on the stem/anchor of E which were only recently shown to become exposed under physiological conditions. For all proteins, except nonstructural protein 2A (NS2A), root-mean-squared-error (RMSE) in predicting distances between pairs held out in each estimation did not outperform sequences of equal length derived from all proteins or E, suggesting that antigenic signals present were likely through linkage with E. Adjusted for E, we identified 62/219 sites embedding the excess signals in NS2A. Concatenating these sites to E additionally explained 3.4% to 4.0% of observed variance in antigenic distances compared to E alone (50.5% to 50.8%); RMSE outperformed concatenating E with sites from any protein of the virus (ΔRMSE, 95%IQR: 0.01, 0.05). Our results support examining antigenic determinants beyond the DENV surface.

Indexed as

DengueDengue VirusAmino AcidsAnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralEpitopesThailandViral Envelope ProteinsAmino AcidsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralEpitopesViral Envelope Proteins

Identifiers

PMID35500035
PMCPMC9098070
OpenAlexW4225286277

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.